
|Slideshows|April 18, 2018
6 New Drugs for Neurologists
Author(s)Susan Kweskin
Newly approved medications for various types of pain, generalized myasthenia gravis, and Parkinson disease will be fodder for discussion at AAN 2018. Here’s a brief overview of the therapies the FDA has approved within the past 6 months.
Advertisement
Newly approved treatments for several neurologic disorders-including various types of pain, generalized myasthenia gravis, and Parkinson Disease-will be topics of discussion at AAN 2018. Here’s a brief overview of those medications FDA approved within the past 6 months.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
The Hidden Burden of Living With Epilepsy
2
FDA Approves Zilganersen, First Treatment for Alexander Disease
3
American Academy of Neurology, American Headache Society Issue Updated Guideline on Migraine Prevention
4
Study Shows DMTs Associated With Higher Risk of Gynecologic Complications in Women With MS
5












